Chest Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dreifus, L. S.
Right arrow Articles by Kimbiris, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dreifus, L. S.
Right arrow Articles by Kimbiris, D.
(Chest. 1963;44:197-200.)
© 1963 American College of Chest Physicians

New Concepts in the Approach to Digitalis Therapy for Atrial Fibrillation

Leonard S. Dreifus M.D.1; Thomas F. McGarry M.D.1; and Demetrios Kimbiris M.D.1

1 Cardiovascular Section, Department of Medicine, Hahnemann Medical College

It has been the purpose of this presentation to bring into sharp focus the precise electrophysiologic mechanisms that may be associated with atrial fibrillation. an approach to the interpretation of these serious cardiac mechanisms has been outlined. Irregularity of the ventricular rate in the presence of atrial fibrillation may be due to a combination of the following electrophysiologic events in the atrioventricular junction: (1) physiologic effective refractory period of the A-V node junctional tissues; (2) interference of subsidiary escape or accelerated A-V nodal pacemakers; (3) concealed A-V conduction in to the A-V junction; (4) entrance block into the A-V nodal tissues, and (5) exit block in the lower regions of the A-V nodal tissues.

Finally, digitalis should be withheld in the presence of independent activation of atria and ventricles due to advanced entrance or exit block, and accelerated nodal rhythm (70-130/min.) A trial of intravenous acetyl strophanthidin (0.5 mg.) may be required when the accelerated nodal rate is greater than 130/min., with intermittent periods of A-V dissociation.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1963 by the American College of Chest Physicians.